Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30640506 | 1.00 | CYP1A2 (0.59) | CYP1A2CYP2A6TDP1TRPM4MAPT | |
| SCHEMBL29952882 | 1.00 | CYP1A2 (0.59) | CYP1A2CYP2A6TDP1TRPM4MAPT | |
| SCHEMBL3186823 | 0.79 | CYP1A2 (0.59) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| SCHEMBL17728164 | 0.78 | CYP1A2 (0.43) | CYP1A2CYP2A6TDP1TRPM4MAPT | |
| SCHEMBL16636625 | 0.78 | NQO2 (0.59) | CYP1A2CYP2A6TRPM4MAPTALDH1A1 | |
| SCHEMBL29892459 | 0.78 | NQO2 (0.59) | CYP1A2CYP2A6TRPM4MAPTALDH1A1 | |
| SCHEMBL31176579 | 0.78 | CYP1A2 (0.43) | CYP1A2CYP2A6TDP1TRPM4MAPT | |
| SCHEMBL29955210 | 0.78 | CYP1A2 (0.43) | CYP1A2CYP2A6TDP1TRPM4MAPT | |
| SCHEMBL368234 | 0.77 | TRPM4 (0.54) | CYP1A2CYP2A6TDP1TRPM4MAPT | |
| SCHEMBL38654678 | 0.77 | CYP2A6 (0.41) | CYP1A2CYP2A6TRPM4MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023214325-A1 | PYRAZOLOPYRIMIDINE DERIVATIVES AND USES THEREOF AS TET2 INHIBITORS | NOVARTIS AG (CH) | 2023-11-09 | — | — | WO | disclosed |
| US-11133476-B2 | Electron transport material, an OLED display panel and an electronic device compromising the same | Shanghai Tianma AM-OLED Co., Ltd. (CN) | 2021-09-28 | — | — | US | disclosed |
| US-20170338422-A1 | Electron Transport Material, An OLED Display Panel And An Electronic Device Compromising The Same | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-11-23 | — | — | US | disclosed |
| US-20170338422-A1 | Electron Transport Material, An OLED Display Panel And An Electronic Device Compromising The Same | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11133476-B2 | Electron transport material, an OLED display panel and an electronic device compromising the same | OCIAD1, OCIAD2, SLCO4C1 | CYP1A2 868/4885CYP2A6 2718/4885TDP1 984/4885 |
| US-20170338422-A1 | Electron Transport Material, An OLED Display Panel And An Electronic Device Compromising The Same | OCIAD1, OCIAD2, SLCO4C1 | CYP1A2 868/4885CYP2A6 2718/4885TDP1 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.